Advances in the discovery of exosome inhibitors in cancer

Huarui Zhang1,2, Jun Lu1,3,2, Jin Liu1,2

  • 1Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases (TMBJ), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.

Insights

Exosomes are key in cell communication and cancer progression. Inhibiting exosome release offers a promising cancer treatment strategy, with ongoing research into novel exosome inhibitors.

Area of Science:

  • Cell Biology
  • Oncology
  • Biochemistry

Background:

  • Exosomes are vital vesicles mediating cell-to-cell communication.
  • Exosomes play a significant role in the progression of various cancers.
  • Targeting exosome release presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To review the development of exosome inhibitors.
  • To discuss currently discovered exosome inhibitors.
  • To provide guidance for future inhibitor development.

Main Methods:

  • Literature review of exosome inhibitor research.
  • Analysis of synthetic compounds and existing drugs with inhibitory potential.
  • Discussion of exosome inhibitor discovery and development.

Main Results:

  • Exosome inhibitors are primarily derived from synthetic compounds.
  • Some existing drugs demonstrate potential in inhibiting exosome release.
  • Significant efforts are directed towards discovering potent and selective exosome inhibitors.

Conclusions:

  • Exosome inhibition is a promising avenue for cancer therapy.
  • Further research is needed to develop novel and effective exosome inhibitors.
  • Understanding exosome biology is crucial for advancing cancer treatment strategies.